您要查找的是不是:
- hemocoagulase aeutus 尖吻蝮蛇凝血酶
- Group 2 was infused with hemocoagulase only. 组2:单用凝血酶(方法同上)。
- Hemocoagulase group does not increase the adverse reaction. 巴曲亭组未出现不良反应。
- Objective To evaluate the efficiency and safety of hemocoagulase used in general surgery. 目的研究注射用蛇毒血凝酶在普通外科中大型手术中止血的有效性及安全性。
- Objective To study the hemostatic effect of China-made hemocoagulase used perioperatively in orthopaedic surgeries. 摘要目的研究国产蛇毒血凝酶(巴曲亭)在骨科手术围术期应用的止血作用。
- Conclusion Hemocoagulase can be used in orthopaedic surgeries as a safe and effective hemostatic agent. 结论蛇毒血凝酶(巴曲亭)可以作为一种安全、有效的止血剂用于骨科手术。
- Nowadays, domestic hemocoagulase preparation is hemocoagulase injection, which cannot be imitated for its protection period. 目前国内血凝酶制剂为注射用血凝酶,但因为保护期未到,无法仿制。
- Conclusion Hemocoagulase is an effctive and safe hemostatic drug in patients during he operation on carcinoma of esophagus and carcinoma of colon. 结论 巴曲亭作为止血药不影响食管癌及结肠癌手术患者的凝血功能,在术中使用是安全的。
- Results Hemocoagulase can reduce the bleeding and transfusion volume in orthopaedie surgeries without significant change of coagulation state. 结果围术期应用蛇毒血凝酶可以显著减少骨科手术的出血量和输血量,但并不影响凝血状态。
- CONCLUSION Hemocoagulase atrox and hemocoagulase are the rather hest hemostatics after transurethral resection of prostate for prostatic hyperplasia patients. 结论注射用血凝酶和白眉蛇毒血凝酶是经尿道前列腺电切术后费用-效益比较佳的止血药。
- Objective To investigate the influence of hemocoagulase injection on blood coagulation function during the operation on carcinoma of esophagus and carcinoma of colon. 目的研究注射用血凝酶(巴曲亭)对食管癌及结肠癌手术患者凝血功能的影响。
- METHODS: Fifty-six patients received abdominal delivery were devided into atrox group (n=29) and control group (n=27) hemocoagulase atrox 2 U was adminstrated iv drip 30 min before operation, 2 U was adminstrated iv drip 2 h after operation. 方法:剖宫产手术产妇 56例,分为血凝酶组(29例)和对照组(27例),血凝酶组术前 30min用血凝酶 2单位静脉注射(静注 ),术后 2h血凝酶 2单位静注。
- RESULTS The efficacy rates of etamsylate, carbazochrome, hemocoagulase atrox and hemocoagulase were 62%, 65%, 83% and 85%, while the cost-benefit ratios of them were 51, 55, 39 and 39, respectively. 结果酚磺乙胺、卡络磺钠、血凝酶和白眉蛇毒血凝酶的有效率分别为62%25、65%25、83%25和85%25;费用-效益比分别为51、55、39和39。
- Methods:122 patients were divided into hemocoagulase-treated group(TG, 49 cases) and control group(CG, 73 cases), TG were used with hemocoagulase, and the other treatments were as same as those in CG. 方法:肝硬化食管胃底静脉曲张破裂出血患者122例,分治疗组49例和对照组73例,治疗组在对照组治疗的基础上加用血凝酶,比较两组的有效率如止血时间、输血量的变化。
- Results The haemostatic rate of patients treated with Yunnan White Drug powder and tranexamic acid was 95.0%,and hemocoagulase and artificial hibernation combination group was 86.4%. 结果20例小量咯血经云南白药和止血芳酸治疗后;有效止血率95.;0%25;22例中至大量咯血联合应用蛇毒血凝素和人工冬眠治疗;有效止血率为86
- Hemocoagulase for injection (HFI) 消化道出血
- Hemostatic effect of hemocoagulase atrox in abdominal delivery 血凝酶对剖宫产术中出血的影响
- Keywords Hemocoagulase;Desmopressin;Activated clotting time(ACT); 血凝酶;去氨加压素;全血激活凝固时间;
- Haemostatic effects of hemocoagulase for injection in a surgical procedure 注射用白眉蛇毒血凝酶对外科手术切口的止血效果
- Application of hemocoagulase atrox in donor site of patients with severe burn injury 血凝酶在大面积深度烧伤患者供皮区中的应用